BNP Paribas Financial Markets Purchases Shares of 716,668 ADC Therapeutics SA (NYSE:ADCT)
Summary by defenseworld.net
1 Articles
1 Articles
All
Left
Center
1
Right
BNP Paribas Financial Markets Purchases Shares of 716,668 ADC Therapeutics SA (NYSE:ADCT)
BNP Paribas Financial Markets purchased a new stake in ADC Therapeutics SA (NYSE:ADCT – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 716,668 shares of the company’s stock, valued at approximately $1,426,000. BNP Paribas Financial Markets owned about 0.74% of ADC Therapeutics as of its most recent filing with the SEC. Other institutional investors and hedge funds also recently bought…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage